This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Hang on a second…

This CME Activity has expired and is no longer available for credit.

Enhancing Glycemic Control in T2DM: 62-Year-Old White Male with T2DM

Enhancing Glycemic Control in T2DM: 62-Year-Old White Male with T2DM


Patient Case Study

Time to Complete

0.50 hours


December 21, 2012


December 21, 2013

Maximum Credits

0.50 / AMA PRA Category 1 Credit(s)TM

Accredited Provider

This program is sponsored by Joslin Diabetes Center.
Produced by Haymarket Medical Education
Commercial Supporter
Supported by an educational grant from Daiichi Sankyo, Inc., and Lilly USA, LLC. For further information concerning Lilly grant funding visit

Program Description

Inadequately managed diabetes leaves patients vulnerable to a host of complications that include diabetic peripheral neuropathy (DPN). Although it can be debilitatingly painful, DPN requires clinical attention even when asymptomatic or only mildly asymptomatic. Because good glycemic control can stabilize or potentially improve this condition, DPN may help motivate patient engagement in self-care for diabetes.

Intended Audience

Primary Care Physicians, Nurse Practitioners, Physician Assistants

Educational Objectives

After taking part in this educational activity, participants should be better able to:
  • Describe the interrelated pathophysiologic abnormalities that contribute to progressive beta‐cell failure and to the clinical manifestations and complications of T2DM
  • Apply current evidence‐based guidelines and expert recommendations for modifying and advancing therapy when glycemic goals for T2DM have not been met
  • Identify potential barriers to effective self‐management in patients with T2DM and devise practical strategies to help address those obstacles
  • Devise strategies that foster better control of glycemic patterns, particularly postprandial glucose levels, in people with T2DM


Richard S. Beaser, MD (Course Director/Chair)
Medical Executive Director
Professional Education
Joslin Diabetes Center
Associate Clinical Professor of Medicine
Harvard Medical School
Boston, MA

Richard S. Beaser, MD, has no relevant relationships to disclose.

Seth N. Braunstein, MD, PhD
Associate Professor of Medicine
Hospital of the University of Pennsylvania
Philadelphia, PA

Seth N. Braunstein, MD, PhD, has no relevant relationships to disclose.

Patricia Bonsignore, RN, CDE, MS
Manager, Clinical Education Programs, HCS
Joslin Diabetes Center
Boston, MA

Patricia Bonsignore, RN, CDE, MS, has no relevant relationships to disclose.

Robert E. Heinig, MD
Chief of Endocrinology/Metabolism
Rochester General Hospital
Clinical Professor of Medicine
University of Rochester School of Medicine
Rochester, NY

Robert E. Heinig, MD, has received grants/research support from CV Therapeutics, Inc., Novartis, AstraZeneca, and Daiichi Sankyo, Inc., and consulting fees from CV Therapeutics, Inc., AstraZeneca, and Merck & Co., Inc.

Publishing Staff Disclosures

Jill Rovitzky Black, Melissa Johnson, and Anne Bardsley, Haymarket Medical Education, have nothing to disclose with regard to commercial support.




AMA PRA Category 1 Credit(s)TM

Accreditation Statement

The Joslin Diabetes Center, Boston, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The Joslin Diabetes Center designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of approved and/or investigational uses of agents that are not indicated by the FDA. The Joslin Diabetes Center, Lilly USA, LLC, and Haymarket Medical Education do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Joslin Diabetes Center, Lilly USA, LLC, and Haymarket Medical Education. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.


To obtain credit, a score of 70% or better is required. This CE is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the posttest survey, and have received your digital copy of your credit certificate. Your online certificate will be saved on within your Profile/Exam History, which you can then access at any time.

If you have any questions regarding this activity, send an e-mail to

Copyright © 2012 by Joslin Diabetes Center, Inc. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Joslin Diabetes Center is prohibited.

Privacy Policy


Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue